Author Correction: Eriodictyol attenuates osteoarthritis progression through inhibiting inflammation via the PI3K/AKT/NF-κB signaling pathway

Eitemau Tebyg

• Eriodictyol attenuates osteoarthritis progression through inhibiting inflammation via the PI3K/AKT/NF-κB signaling pathway
  gan: Wenbo Kang, et al.
  Cyhoeddwyd: (2024-08-01)
• Eriodictyol Inhibits Proliferation, Metastasis and Induces Apoptosis of Glioma Cells via PI3K/Akt/NF-κB Signaling Pathway
  gan: Wenjun Li, et al.
  Cyhoeddwyd: (2020-02-01)
• Eriodictyol Suppresses Gastric Cancer Cells via Inhibition of PI3K/AKT Pathway
  gan: Hui Shan, et al.
  Cyhoeddwyd: (2022-11-01)
• Hyperoside attenuates osteoarthritis progression by targeting PI3K/Akt/NF-κB signaling pathway: In vitro and in vivo studies
  gan: Yang Yang, et al.
  Cyhoeddwyd: (2022-08-01)
• Eriodictyol attenuates TNBS‐induced ulcerative colitis through repressing TLR4/NF‐kB signaling pathway in rats
  gan: Li‐Hong Hu, et al.
  Cyhoeddwyd: (2021-09-01)